BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

IDev Technologies, Inc. Strengthens Commercial Leadership


6/7/2012 9:55:39 AM

WEBSTER, Texas, June 6, 2012 /PRNewswire/ -- IDEV Technologies, Inc. (IDEV), an emerging innovator in peripheral vascular devices, announced the hiring of Trent Reutiman as Vice President, Global Commercial Operations. He joins the company after successful sales and marketing positions at ROX Medical and several other start-ups. His early career was in sales and sales management at Guidant and Cordis.

In addition to Reutiman, IDEV has further supplemented the global team with additional hires in key areas including the commercial organization, product development, and operations as the company continues to develop its business through organic growth, new product launches, and geographic expansion.

"The addition of Trent to our senior management team is a reflection of our commitment to further expand our capabilities, and to execute our long term strategy," commented Christopher Owens, President and CEO of IDEV. "All the new resources bring global experience that further enhances our existing organization as we work to develop and complement our unique technology platform."

Reutiman, in this newly created role, will lead the global sales and marketing teams as the company continues to expand distribution and sales of its flagship product, the SUPERA® stent.

"I'm excited to join IDEV at this time," commented Reutiman. "With recent product launches in multiple countries in the Asia Pacific region, continued market penetration in Europe, and intense preparations for the anticipated FDA approval of the SUPERA stent in the U.S., we are setting strategies that are vital to successful commercial execution."

About IDEV Technologies, Incorporated
IDEV Technologies, Incorporated (IDEV) is an innovator and developer of next generation medical devices for use in interventional radiology, vascular surgery and cardiology. IDEV's worldwide headquarters is located in Webster, Texas and its European headquarters is located in Beuningen, The Netherlands.

The SUPERA stent is currently indicated in the United States for the palliative treatment of biliary strictures produced by malignant neoplasms and in multiple other countries for the treatment of biliary strictures produced by malignant neoplasms and for peripheral vascular use following failed percutaneous transluminal angioplasty (PTA).

For more information please visit www.idevmd.com.

Contact:

Donna Lucchesi


Vice President Global Marketing


IDEV Technologies, Incorporated


(281) 525-2000

SOURCE IDEV Technologies, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES